Department of Economics and Business, Universitat Pompeu Fabra / Working Papers, Research Center on Health and Economics
Raw citation data, Impact Factor, Immediacy Index, Published documents, Citations received, , Most cited papers , Recent citations and documents published in this series in EconPapers. Create citation feed for this series
  Most cited documents in this series: (1) RePEc:upf:upfses:662 Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy (2003). Cited: 5 times. (2) RePEc:upf:upfses:757 Regional Differences in Socio-Economic Health Inequalities in Spain (2004). Cited: 4 times. (3) RePEc:upf:upfses:704 Demand for Pharmaceutical Drugs: A Choice Modelling Experiment (2003). Cited: 4 times. (4) RePEc:upf:upfses:531 Demand for Private Health Insurance: Is there a Quality Gap? (2001). Cited: 3 times. (5) RePEc:upf:upfses:676 A Consistency Test of the Time Trade-Off (2003). Cited: 3 times. (6) RePEc:upf:upfses:632 Are Tax Subsidies for Private Medical Insurance Self-financing? Evidence from a Microsimulation Model for Outpatient and Inpatient Episodes (2004). Cited: 2 times. (7) RePEc:upf:upfses:240 Unobserved Heterogeneity and Censoring in the Demand for Health Care (1997). Cited: 2 times. (8) RePEc:upf:upfses:745 Diversity and Regional Inequalities: Assessing the Outcomes of the Spanish System of Health Care Services (2004). Cited: 2 times. (9) RePEc:upf:upfses:307 Las deducciones en el IRPF por gasto sanitario privado: situación actual y posibilidades de reforma (1998). Cited: 2 times. (10) RePEc:upf:upfses:719 Cost Efficiency in Primary Care Contracting: A Stochastic Frontier Cost Function Approach (2003). Cited: 1 times. (11) RePEc:upf:upfses:362 Review of the Literature on Reference Pricing (1999). Cited: 1 times. (12) RePEc:upf:upfses:762 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain (2004). Cited: 1 times. (13) RePEc:upf:upfses:609 La imposición de los carburantes de automoción en España: algunas observaciones teóricas y empÃricas (2002). Cited: 1 times. (14) RePEc:upf:upfses:524 The Impact of the Reference Price System on the Pharmaceutical Market: A Theoretical Approach (2003). Cited: 1 times. (15) RePEc:upf:upfses:711 Measurement and Explanation of Socioeconomic Inequality in Health with Longitudinal Data (2003). Cited: 1 times. (16) RePEc:upf:upfses:797 Responsabilidad Social Corporativa. Una Visión desde la TeorÃa Económica (2004). Cited: 1 times. Recent citations received in: | 2006 | 2005 | 2004 | 2003 Recent citations received in: 2006 Recent citations received in: 2005 Recent citations received in: 2004 (1) RePEc:upf:upfgen:762 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain (2004). Department of Economics and Business, Universitat Pompeu Fabra / Economics Working Papers (2) RePEc:upf:upfses:762 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain (2004). Department of Economics and Business, Universitat Pompeu Fabra / Working Papers, Research Center on Health and Economics Recent citations received in: 2003 (1) RePEc:upf:upfgen:705 Eliciting Consumers Preferences Using Stated Preference Discrete Choice Models: Contingent Ranking versus Choice Experiment (2003). Department of Economics and Business, Universitat Pompeu Fabra / Economics Working Papers (2) RePEc:upf:upfses:524 The Impact of the Reference Price System on the Pharmaceutical Market: A Theoretical Approach (2003). Department of Economics and Business, Universitat Pompeu Fabra / Working Papers, Research Center on Health and Economics (3) RePEc:upf:upfses:705 Eliciting Consumers Preferences Using Stated Preference Discrete Choice Models: Contingent Ranking versus Choice Experiment (2003). Department of Economics and Business, Universitat Pompeu Fabra / Working Papers, Research Center on Health and Economics Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results. Source data used to compute the impact factor of RePEc series.
|